https://www.selleckchem.com/pr....oducts/abtl-0812.htm
dministration in vivo can inhibit the growth of the tumors. To explore the impact of induction treatment response on the prognosis of pediatric core binding factor-acute myeloid leukemia (CBF-AML). The result of induce reaction and survival data of 157 pediatric CBF-AML patients in our hospital from September 2008 to December 2018 were retrospectively analyzed．The survival rate of the patients with different degrees of morphological remission after induction chemotherapy was comparative analyzed. Among the 157 children with CBF-AML, 1
Like
Comment
Share
